Mr. Feng (Chinese) is currently Vice President of Sinochem Group. At present, Mr. Feng also acts as Board Member of Sinochem Corporation, Chairman and General Manager of Sinochem Lantian Group Co., Ltd.
Since January 2015 Mr. Feng is Chairman of the Board of DSM Sinochem Pharmaceuticals.
Mr. Dong Jianhua (Chinese) currently is the General Manager and Executive Director of Sinochem Jiangsu Limited, the pharmaceuticals business platform in Sinochem Group. He has worked in Canada for four years and acted as Vice-Chairman of a joint venture between Sinochem and Royal Vopak.
Since July 2012 he is a Board Member and Remuneration Audit Committee Member of DSM Sinochem Pharmaceuticals.
Mr. Jiang (Chinese) is the general manager of Treasury Department of Sinochem Group. He also acts as Board Member of Sinochem Petroleum Exploration and Production Co., Ltd, Sinochem Quanzhou Petrochemical Co., Ltd, Sinochem Finance Co., Ltd, China Foreign Economy and Trade Trust Co., Ltd, and Manulife-Sinochem.
Since April 2016 he is a Board Member and Remuneration Committee Member of DSM Sinochem Pharmaceuticals.
Mr. Jiang (Danish) currently is the President of DSM China.
Before joining DSM, Mr. Jiang, worked for Novozymes where he was actively involved in the development of a biotech-industry platform in China. He also contributed to an increased awareness and implementation of sustainable entrepreneurship in China, amongst other things in his capacity as vice-chairman of the China Business Council for Sustainable Development.
Since August 2011 he is a member of the Board of DSM Sinochem Pharmaceuticals.
Dimitri de Vreeze (Dutch) is a member of the Managing Board of DSM, where he is responsible for DSM’s Materials cluster, consisting of DSM Engineering Plastics, DSM Dyneema and DSM Resins & Functional Materials.
He also oversees DSM’s business in the Netherlands and Asia, and is responsible for Group Sourcing.
Dimitri joined the Board of DSM Sinochem Pharmaceuticals in January 2017.
Philip Eykerman (Belgian) is Executive Vice President Corporate Strategy & Acquisitions at DSM, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board of DSM.
Before joining DSM Mr. Eykerman was a Partner at McKinsey in Brussels, leading their Chemicals Practice in the Benelux and France. He has been heavily involved in a number of significant strategy development, transformation and M & A projects in the broader chemicals industry.
He became a member of the Board of DSM Sinochem Pharmaceuticals on January 2016.